Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
India Glycols Limited ( (IN:INDIAGLYCO) ) has shared an announcement.
India Glycols Limited held a court-convened meeting of its equity shareholders on 24 March 2026 via video conference, as directed by the National Company Law Tribunal, Allahabad Bench. The meeting was properly constituted with appointed chairpersons and a scrutinizer, and shareholders were able to participate, inspect documents electronically, and raise questions through multiple digital channels.
The sole resolution placed before shareholders, relating to a Scheme of Arrangement among India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited and their respective shareholders, was approved with the requisite majority. Voting results and the consolidated scrutinizer’s report have been filed with the stock exchanges and made available on the company and NSDL websites, marking a key step forward in implementing the proposed corporate restructuring.
More about India Glycols Limited
India Glycols Limited operates in the chemicals and bio-based products sector, with a focus on industrial chemicals, specialty chemicals, and related value-added products. The company serves domestic and international markets and is listed on both BSE and the National Stock Exchange of India under the symbol INDIAGLYCO.
Average Trading Volume: 6,276
Technical Sentiment Signal: Buy
Current Market Cap: 54.85B INR
For an in-depth examination of INDIAGLYCO stock, go to TipRanks’ Overview page.